August 31, 2026

Oscar Health, Inc. (OSCR) Stock Analysis: Is the Recent 70.4% Revenue Growth a Sign of More to Come?

Oscar Health, Inc. (NYSE: OSCR), a dynamic player in the healthcare technology sector, has caught the eye of investors with its notable 70.4% revenue growth. This impressive figure, coupled with..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring the Biotech’s Steady Path with a $9.81 Billion Market Cap

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the biotechnology sector with a market capitalization of $9.81 billion. Despite the stock’s current..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 19.6% Potential Upside in Healthcare Services

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, particularly within the medical care facilities industry, offering a diverse range of infusion services across the United States...

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Gem with 43% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its promising outlook in the biotechnology sector. As a company focused on developing innovative therapies for central nervous..

Solventum Corporation (SOLV) Stock Analysis: Understanding the Healthcare Giant’s 3.08% Potential Upside

In the world of healthcare investments, Solventum Corporation (SOLV) stands out as a promising player commanding a market capitalization of $15.51 billion. Specializing in medical instruments and supplies, Solventum showcases..

Rhythm Pharmaceuticals (RYTM): Investor Outlook on a 30.81% Potential Upside in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a prominent player in the biopharmaceutical sector, offers a compelling investment opportunity for those interested in the rapidly evolving landscape of biotechnology. Specializing in rare..

Viatris Inc. (VTRS) Stock Analysis: Exploring Its 13% Upside Potential and Dividend Appeal

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, particularly in the drug manufacturing industry, where it specializes in both specialty and generic pharmaceuticals. With a..

TransMedics Group, Inc. (TMDX) Investor Outlook: Harnessing a 10% Upside Potential in Medical Devices

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the healthcare sector, is making waves with its innovative approach to organ transplant therapy. Known for its Organ Care System (OCS), the..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating a Challenging Market with Strategic Insights

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the manufacturing of medical devices, catering to a diverse range of medical needs from interventional cardiology..

Novartis AG (NVS): Investor Outlook on a Healthcare Giant with Promising Upside

Novartis AG (NYSE: NVS), a Swiss-based titan in the healthcare sector, has long been a stalwart in the pharmaceutical industry. With a robust market capitalization of $292.35 billion, the company..

Charles River Laboratories (CRL) Stock Analysis: Navigating Growth Challenges with Strategic Collaborations

Charles River Laboratories International, Inc. (NYSE: CRL) operates in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $14.04 billion, the company plays a..

Alkermes plc (ALKS) Stock Analysis: Exploring an 18% Potential Upside with a Solid Revenue Growth Story

Alkermes plc (NASDAQ: ALKS), an innovative player in the biopharmaceutical sector, presents an intriguing opportunity for investors with its current market position. Headquartered in Dublin, Ireland, Alkermes specializes in addressing..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unpacking a 40.78% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a notable player in the biotechnology sector, focused on developing therapies for severe and rare diseases. With a market capitalization of $12.52 billion,..

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating a Healthcare Giant with 11.67% Upside Potential

Fresenius Medical Care AG (FMS), a key player in the healthcare sector, specializes in providing dialysis and related services across the globe. With a market cap of $12.29 billion, this..

Ionis Pharmaceuticals (IONS) Stock Analysis: Evaluating a 44% Potential Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands at the forefront of the biotechnology industry with its innovative RNA-targeted medicines. Headquartered in Carlsbad, California, this healthcare sector player is attracting significant investor..

Moderna, Inc. (MRNA) Stock Analysis: Navigating Volatility in Biotechnology with a Potential 22.73% Downside

For investors focusing on the dynamic biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) presents a compelling yet complex opportunity set against the backdrop of an ever-evolving healthcare landscape. Positioned as a..

Bausch + Lomb Corporation (BLCO) Stock Report: Analyzing a 9.10% Revenue Growth in the Healthcare Sector

Investors keeping a close eye on the healthcare sector might find Bausch + Lomb Corporation (NYSE: BLCO) an intriguing prospect. As a key player in the Medical Instruments & Supplies..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Potential Upside Amidst Robust Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a key player in the Diagnostics & Research sector, commands attention with its robust $28.02 billion market capitalization. Operating from its headquarters in Greifensee, Switzerland,..

Grifols, S.A. (GRFS) Stock Analysis: A Potential 41% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS) presents a compelling investment opportunity in the healthcare sector, known for its robust portfolio of plasma-derived medicines. Headquartered in Barcelona, Spain, Grifols operates globally, enhancing its..

West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a formidable player in the healthcare sector, is capturing the attention of investors with its robust market presence and promising growth metrics. As a..

Search

Funds

August 31, 2026

Search

Funds

August 31, 2026

FTSE 100

Funds